The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer
The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The epidermal growth factor receptor (EGFR) is a potential target of anticancer therapy in gastric cancer. However, its prognostic role in metastatic gastric or gastroesophageal junction (GE) cancer has not been established yet.
EGFR status was analyzed by immunohistochemistry (IHC) in paraffin-embedded samples from 357 patients who received che...
Alternative Titles
Full title
The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_334e6b1ddf064b6e9036a70c5f9bc71a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_334e6b1ddf064b6e9036a70c5f9bc71a
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/1471-2407-12-524
